Last10K.com

Advansource Biomaterials Corp (ASNB) SEC Filing 10-K Annual report for the fiscal year ending Saturday, March 31, 2018

Advansource Biomaterials Corp

HISTORY TOOLS
CIK: 1011060 Ticker: ASNB
Document and Entity Information - USD ($)
12 Months Ended
Mar. 31, 2018
Sep. 30, 2017
Document and Entity Information:  
Entity Registrant NameAdvansource Biomaterials Corp 
Document Type10-K 
Document Period End DateMar. 31, 2018 
Amendment Flagfalse 
Entity Central Index Key0001011060 
Current Fiscal Year End Date--03-31 
Entity Common Stock, Shares Outstanding21,490,621 
Entity Public Float $ 1,738,000
Entity Filer CategorySmaller Reporting Company 
Entity Current Reporting StatusYes 
Entity Voluntary FilersNo 
Entity Well-known Seasoned IssuerNo 
Document Fiscal Year Focus2018 
Document Fiscal Period FocusFY 
Trading Symbolasnb 

View differences made from one year to another to evaluate Advansource Biomaterials Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advansource Biomaterials Corp.

Continue

Assess how Advansource Biomaterials Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advansource Biomaterials Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Balance Sheets
Statement Of Cash Flows
Statements Of Operations
Statements Of Stockholders' Equity
Benefit Plans And Employment Agreements Of Executive Officers
Concentrations Of Credit Risk And Major Customers
Contingencies
Description Of Business
Income Taxes
Income Taxes (details)
Income Taxes: Schedule Of Deferred Tax Assets And Liabilities (details)
Income Taxes: Schedule Of Deferred Tax Assets And Liabilities (tables)
Income Taxes: Schedule Of Effective Income Tax Rate Reconciliation (tables)
Income Taxes: Summary Of Operating Loss Carryforwards (tables)
Inventories
Inventories: Schedule Of Inventory (details)
Inventories: Schedule Of Inventory (tables)
Liquidity
Long-term Financing Obligation
Long-term Financing Obligation: Schedule Of Sale Leaseback Transactions (tables)
Promissory Notes
Property, Plant And Equipment Disclosure
Property, Plant And Equipment Disclosure (details)
Property, Plant And Equipment Disclosure: Property, Plant And Equipment (details)
Property, Plant And Equipment Disclosure: Property, Plant And Equipment (tables)
Related Party Transactions
Stock-based Compensation
Stock-based Compensation: Schedule Of Share-based Compensation Activity (tables)
Stockholders' Equity
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies: Accounting Principles (policies)
Summary Of Significant Accounting Policies: Accounts Receivable (details)
Summary Of Significant Accounting Policies: Accounts Receivable (policies)
Summary Of Significant Accounting Policies: Advertising Costs (policies)
Summary Of Significant Accounting Policies: Basic And Diluted Earnings (loss) Per Share (policies)
Summary Of Significant Accounting Policies: Cash (policies)
Summary Of Significant Accounting Policies: Deferred Financing Costs (details)
Summary Of Significant Accounting Policies: Deferred Financing Costs (policies)
Summary Of Significant Accounting Policies: Fair Value Of Financial Instruments (policies)
Summary Of Significant Accounting Policies: Impairment Of Long-lived Assets (policies)
Summary Of Significant Accounting Policies: Income Taxes (policies)
Summary Of Significant Accounting Policies: Inventories (details)
Summary Of Significant Accounting Policies: Inventories (policies)
Summary Of Significant Accounting Policies: Property And Equipment (policies)
Summary Of Significant Accounting Policies: Recent Accounting Pronouncements (policies)
Summary Of Significant Accounting Policies: Research, Development And Regulatory Expense (policies)
Summary Of Significant Accounting Policies: Revenue Recognition Accounting Policy (policies)
Summary Of Significant Accounting Policies: Stock-based Compensation (policies)
Summary Of Significant Accounting Policies: Use Of Accounting Estimates (policies)

Material Contracts, Statements, Certifications & more

Advansource Biomaterials Corp provided additional information to their SEC Filing as exhibits

Exhibit 23.1: Consents Of Experts And Counsel
Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: ASNB
CIK: 1011060
Form Type: 10-K Annual Report
Accession Number: 0001556244-18-000089
Submitted to the SEC: Mon Jul 16 2018 2:49:49 PM EST
Accepted by the SEC: Mon Jul 16 2018
Period: Saturday, March 31, 2018
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/asnb/0001556244-18-000089.htm